Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/26395
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2022-05-11T12:27:25Z | - |
dc.date.available | 2022-05-11T12:27:25Z | - |
dc.date.issued | 2012-02-21 | - |
dc.identifier.citation | Ölmez, Ö. F. vd. (2012). "Clinical outcomes of lung metastasectomy in patients with colorectal cancer". World Journal of Gastroenterology, 18(7), 662-665. | en_US |
dc.identifier.issn | 1007-9327 | - |
dc.identifier.uri | https://doi.org/10.3748/wjg.v18.i7.662 | - |
dc.identifier.uri | https://www.wjgnet.com/1007-9327/full/v18/i7/662.htm | - |
dc.identifier.uri | http://hdl.handle.net/11452/26395 | - |
dc.description.abstract | AIM: To investigate prognostic factors of survival following curative, non-palliative surgical removal of lung metastases secondary to colorectal cancer (CRC). METHODS: Between 1999 and 2009, a radical metastasectomy with curative intent was performed on lung metastases in 21 patients with CRC (15 male and 6 female; mean age: 57.4 +/- 11.8 years; age range: 29-74 years) who had already undergone primary tumour resection. RESULTS: The mean number of lung metastases ranged from one to five. The mean overall survival was 71 +/- 35 mo (median: 25 mo). After adjusting for potential confounders, multivariable Cox regression analyses predicted only the number of lung metastases (1 vs >= 2; hazard ratio: 7.60, 95% confidence interval: 1.18-17.2, P = 0.03) as an independent predictor of poor survival following lung resection for metastatic CRC. CONCLUSION: Resection of lung metastases is a safe and effective treatment in selected CRC patients with single lung metastases. (C) 2012 Baishideng. All rights reserved. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Baishideng Publishing Group | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.rights | Atıf Gayri Ticari Türetilemez 4.0 Uluslararası | tr_TR |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Gastroenterology & hepatology | en_US |
dc.subject | Lung metastases | en_US |
dc.subject | Colorectal cancer | en_US |
dc.subject | Metastasectomy | en_US |
dc.subject | Prognostic factors | en_US |
dc.subject | Survival | en_US |
dc.subject | Pulmonary metastases | en_US |
dc.subject | Surgical resection | en_US |
dc.subject | Prognostic-factors | en_US |
dc.subject | Carcinoma | en_US |
dc.subject | Survival | en_US |
dc.subject | Surgery | en_US |
dc.title | Clinical outcomes of lung metastasectomy in patients with colorectal cancer | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000300600900009 | tr_TR |
dc.identifier.scopus | 2-s2.0-84857425190 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Göğüs Cerrahisi Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-9732-5340 | tr_TR |
dc.identifier.startpage | 662 | tr_TR |
dc.identifier.endpage | 665 | tr_TR |
dc.identifier.volume | 18 | tr_TR |
dc.identifier.issue | 7 | tr_TR |
dc.relation.journal | World Journal of Gastroenterology | en_US |
dc.contributor.buuauthor | Ölmez, Ömer Fatih | - |
dc.contributor.buuauthor | Çubukçu, Erdem | - |
dc.contributor.buuauthor | Bayram, Ahmet Sami | - |
dc.contributor.buuauthor | Akçalı, Ünsal | - |
dc.contributor.buuauthor | Evrensel, Türkkan | - |
dc.contributor.buuauthor | Gebitekin, Cengiz | - |
dc.contributor.researcherid | AAJ-1027-2021 | tr_TR |
dc.contributor.researcherid | ABB-7580-2020 | tr_TR |
dc.identifier.pubmed | 22363137 | tr_TR |
dc.subject.wos | Gastroenterology & hepatology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q2 | en_US |
dc.contributor.scopusid | 26435400000 | tr_TR |
dc.contributor.scopusid | 53986153800 | tr_TR |
dc.contributor.scopusid | 8347194000 | tr_TR |
dc.contributor.scopusid | 16027743900 | tr_TR |
dc.contributor.scopusid | 6603942124 | tr_TR |
dc.contributor.scopusid | 6602156436 | tr_TR |
dc.subject.scopus | Metastasectomy; Sarcoma; Lung Cancer | en_US |
dc.subject.emtree | Carcinoembryonic antigen | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Aged | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Cancer chemotherapy | en_US |
dc.subject.emtree | Cancer localization | en_US |
dc.subject.emtree | Cancer prognosis | en_US |
dc.subject.emtree | Cancer size | en_US |
dc.subject.emtree | Cancer survival | en_US |
dc.subject.emtree | Clinical article | en_US |
dc.subject.emtree | Colorectal cancer | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Disease free survival | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Liver metastasis | en_US |
dc.subject.emtree | Lung metastasis | en_US |
dc.subject.emtree | Lymph node metastasis | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Medical history | en_US |
dc.subject.emtree | Metastasis resection | en_US |
dc.subject.emtree | Outcome assessment | en_US |
dc.subject.emtree | Overall survival | en_US |
dc.subject.emtree | Post treatment survival | tr_TR |
dc.subject.emtree | Postoperative care | en_US |
dc.subject.emtree | Preoperative evaluation | en_US |
dc.subject.emtree | Tertiary health care | en_US |
dc.subject.emtree | Tumor differentiation | en_US |
dc.subject.emtree | Turkey (republic) | en_US |
dc.subject.emtree | Wedge resection | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Ölmez_vd_2012.pdf | 654.75 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License